التفاصيل البيبلوغرافية
| العنوان: |
The benefits of HIV resistance testing in optimizing drug discovery. |
| المؤلفون: |
Heilek-Snyder G; Inflammatory and Viral Diseases Unit, Roche BioSciences, 3401 Hillview Ave., Palo Alto, CA 94304, USA. gabrielle.heilek-snyder@roche.com, Bean P |
| المصدر: |
American clinical laboratory [Am Clin Lab] 2002 Oct; Vol. 21 (8), pp. 13-4. |
| نوع المنشور: |
Journal Article |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: International Scientific Communications, Inc Country of Publication: United States NLM ID: 8903666 Publication Model: Print Cited Medium: Print ISSN: 1041-3235 (Print) Linking ISSN: 10413235 NLM ISO Abbreviation: Am Clin Lab |
| أسماء مطبوعة: |
Original Publication: [Shelton, CT : International Scientific Communications, Inc., [c1988- |
| مواضيع طبية MeSH: |
Anti-HIV Agents/*pharmacology , HIV Infections/*drug therapy, Drug Design ; Drug Resistance, Viral/genetics ; HIV/drug effects ; HIV/genetics ; HIV Infections/virology ; Humans ; Microbial Sensitivity Tests ; Mutation |
| المشرفين على المادة: |
0 (Anti-HIV Agents) |
| تواريخ الأحداث: |
Date Created: 20021121 Date Completed: 20021216 Latest Revision: 20041117 |
| رمز التحديث: |
20240627 |
| PMID: |
12440169 |
| قاعدة البيانات: |
MEDLINE |
